Half Year Accounts
Summary
- ChemX Materials Limited reported a loss of $1,911,696 after income tax for the period ended December 31, 2023, compared to a loss of $2,449,542 for the same period in the previous year.
- The company reported a maiden JORC Manganese Resource of 13.7mt at 5.7 Mn%.
- The HPA Micro Plant achieved targeted purity levels of 99.99% HPA.
- The larger scale HPA Pilot Plant was under construction during the reporting period.
- Operating cash outflows improved slightly to $1,182,016 from $1,277,451 due to government R&D grants of $919,600.
- The company's cash balance at the end of the reporting period was $1,229,526.
- A $6,000,000 unsecured convertible note funding facility with Mercer Street Global Opportunity Fund, LLC was announced on August 4, 2023.
- $500,000 (Tranche 1) and $1,700,000 (Tranche 2) were drawn from the convertible note facility.
- 2,500,000 Deferred Consideration Shares will be issued upon the commissioning of the HiPurA Pilot Plant.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company is making progress on its projects and has secured funding, it is still operating at a loss and faces challenges in securing additional funding to continue as a going concern.
Highlights
- ChemX Materials Limited reported a loss of $1,911,696 for the half-year ended December 31, 2023.
- The company reported a maiden JORC Manganese Resource of 13.7mt at 5.7 Mn%.
- The HPA Micro Plant achieved targeted purity levels of 99.99% HPA.
- Operating cash outflows improved slightly to $1,182,016 due to government R&D grants of $919,600.
- The company's cash balance at the end of the reporting period was $1,229,526.
- A $6,000,000 unsecured convertible note funding facility was established with Mercer Street Global Opportunity Fund, LLC.
- 2,500,000 Deferred Consideration Shares will be issued upon the commissioning of the HiPurA Pilot Plant.
Positives
- The company achieved targeted purity levels of 99.99% HPA in its HPA Micro Plant.
- Operating cash outflows improved slightly, driven by government R&D grants.
- The company secured a $6,000,000 convertible note funding facility to advance its projects.
- The company reported a maiden JORC Manganese Resource of 13.7mt at 5.7 Mn%.
Negatives
- The company reported a net loss of $1,911,696 for the half-year ended December 31, 2023.
- The Group incurred operating cash outflows of $1,182,016 for the half-year ended 31 December 2023.
- The Group has net current liabilities of $338,216.
Risks
- The company's ability to continue as a going concern is dependent on securing additional funding.
- The company's net current liabilities of $338,216 indicate potential short-term financial challenges.
- The company is subject to risks associated with exploration and evaluation activities, including potential write-offs of capitalised costs.
Future Outlook
The company intends to use the convertible note funding facility to maintain momentum and advance the Eyre Peninsula High purity Alumina and HiPurA HPA Project in Perth, Western Australia.
Management Comments
- The lower corporate expenses reflect management decisions to reduce the use of consultants and appoint roles internally including the replacement of the previous CEO with former Chief Operating Officer, Mr Peter Lee.
Industry Context
The company is operating in the high purity alumina and manganese sectors, which are driven by demand from the battery, electric vehicle, and technology industries.
Comparison to Industry Standards
- The company's HPA Micro Plant achieved purity levels of 99.99%, which is a standard benchmark for high-quality HPA used in various high-tech applications.
- Comparable companies in the HPA sector include Altech Chemicals and Alpha HPA, which are also focused on developing high-purity alumina production capabilities.
- The maiden JORC Manganese Resource of 13.7mt at 5.7 Mn% is a relatively small resource compared to larger manganese miners like South32 or Eramet, but it represents a starting point for potential future development.
Stakeholder Impact
- Shareholders: The net loss may negatively impact shareholder value, but progress on projects and securing funding are positive signs.
- Employees: The company's cost-cutting measures, including internal appointments, may impact employee roles and responsibilities.
- Customers: Progress on the HPA project could lead to future supply agreements and partnerships.
- Creditors: The convertible note facility provides funding but also increases the company's debt obligations.
Next Steps
- Commissioning the HiPurA Pilot Plant, which will trigger the issuance of 2,500,000 Deferred Consideration Shares.
- Continuing the internal scoping study on the maiden JORC Manganese Resource.
- Advancing the Eyre Peninsula High purity Alumina and HiPurA HPA Project in Perth, Western Australia.
Key Dates
- 31 December 2021: Completion of the acquisition of HiPurA Pty Ltd
- 30 June 2022: As at this date, the number of Deferred Consideration Shares pending issue was 4,500,000 at a fair value of $0.20 per share totalling $900,000 which was credited to the share based payments reserve.
- 1 September 2022: The Company issued 2,000,000 Deferred Consideration Shares upon completion of the Flow Sheet Design milestone.
- 4 August 2023: The Company announced a $6,000,000 unsecured convertible note funding facility with Mercer Street Global Opportunity Fund, LLC.
- 14 August 2023: Tranche 1 convertible notes were issued.
- 26 September 2023: Shareholder approval was granted for Tranche 2 of the convertible note funding facility.
- 9 October 2023: Tranche 2 convertible notes were issued and options expire three years after this date.
- 26 October 2023: Tara Berrie resigned as Non-Executive Director.
- 31 December 2023: End of the reporting period.
- 13 March 2024: Date of Directors' report and authorisation of financial statements for issue.
Keywords
Filings with Classifications
Insolvency Announcement
- Benelong Capital Partners (BCP) recapitalisation proposal requires ASIC, ASX and shareholder approval.
Trading Suspension Extension Request
- The company is not ready to announce a Funding Update and Management Restructure, which is causing a delay in trading and is worse than expected.
Trading Suspension Extension Request
- The company is delaying the release of the Funding Update and Management Restructure announcement.
- The trading suspension is being extended due to the delay in the announcement.
Trading Suspension Update
- The company's funding update and management restructure are taking longer than anticipated.
- Negotiations with relevant parties have caused a delay in the announcement.
Suspension Announcement
- The announcement is related to an update on funding, which could indicate a potential capital raise.
Trading Halt Request
- The trading halt is pending an announcement regarding an update on funding, which could indicate a potential capital raise.
Financing Agreement Update
- Mercer has approved ChemX to raise up to $500,000 in additional debt financing.
AGM Presentation
- The commissioning of the 24tpa HPA Pilot Plant has experienced unforeseen delays in recent months, primarily due to the solvent extraction (SX) module awaiting electrical package installation.
AGM Presentation
- The announcement revealed unforeseen delays in the commissioning of the solvent extraction module of the pilot plant, pushing back the timeline for full operation.
R&D Funding Announcement
- The receipt of the R&D refund exceeding the amount of the Radium Capital facility was better than expected, resulting in a surplus for working capital.
Price Query Response
- ChemX is in discussions with third parties regarding potential capital raisings.
- No formal agreements have been reached for any capital raising.
Quarterly Report
- The company has appointed TritonLake as Corporate and Financial Advisors to assist with capital, financing and corporate advisory.
- The company believes it would be successful with raising additional capital.
Quarterly Report
- The delays in the Solvent Extraction module of the pilot plant represent a setback from the expected timeline for commissioning.
Quarterly Report
- Delays were experienced in the construction of the Solvent Extraction (SX) module due to longer than expected lead times on key process equipment and delivery of critical electrical infrastructure.
Notice of Annual General Meeting
- The 7.1A mandate seeks shareholder approval to issue up to 10% of the company's issued capital in equity securities without further shareholder approval.
- The funds raised under the 7.1A mandate are intended to be used for the 24tpa HiPurA high purity alumina (HPA) pilot plant and working capital.
Annual Report
- The company reported a net loss after tax of \$4.49 million, significantly higher than the previous year's loss of \$4.18 million, indicating worse than expected results.
Annual Report
- The company raised \$1,616,600 through a share placement and share purchase plan.
- A \$6,000,000 convertible note funding facility was secured, with potential for further equity dilution upon conversion.
Quarterly Activities Report
- The company has applied for an advance from a funding provider against expected CMX FY24 R&D claim for circa $440,000.
- The Company also has access to financial markets and believes it can successfully raise capital.
Quarterly Activities Report
- The company completed a $1.1M placement.
- A Share Purchase Plan (SPP) is ongoing, aiming to raise up to $500,000.
- Directors have committed to subscribe for 1,354,166 shares, subject to shareholder approval, under the Placement to raise an additional $65,000 at the same issue price.
Share Purchase Plan Extension Announcement
- The closing date of the SPP has been extended from April 23, 2024, to May 10, 2024.
Share Purchase Plan Announcement
- The document mentions that it is highly likely that further funding will be required to meet the medium to long term working capital costs of the Company.
- Any additional equity financing will dilute shareholdings, and debt financing, if available, may involve restrictions on financing and operating activities.
Interim Report
- The company has access to a further $3,800,000 funding under its unsecured convertible note facility, subject to further agreement between the parties.
Interim Report
- The company reported a net loss of $1,911,696 for the half-year ended December 31, 2023, which is worse than breakeven.
Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.